Results 31 to 40 of about 444,660 (199)

Immunosuppressive therapy prevents recurrent pericarditis [PDF]

open access: yes, 1995
Objectives.This study reviews the clinical outcome of a series of patients with recurrent pericarditis before and after immunosuppressive therapy.Background.Despite anti-inflammatory treatment, some patients with acute pericarditis experience repeated ...
Renzo Marcolongo   +9 more
core   +1 more source

Recurrent pericarditis in a patient with Bardet–Biedl syndrome: A case report

open access: yesFrontiers in Pediatrics, 2022
Bardet–Biedl syndrome is a rare autosomal recessive disorder characterized by rod-cone dystrophy, renal dysfunction, obesity, learning difficulties, hypogonadism, polydactyl, and many other minor features that can affect the cardiovascular, locomotive ...
Angela Mauro   +8 more
doaj   +1 more source

Assessing the Impact of Rilonacept on Lipid Profiles in Patients With Recurrent Pericarditis [PDF]

open access: yesJACC: Advances
Aqieda Bayat, MD   +6 more
doaj   +2 more sources

Genetic variants in patients with recurrent pericarditis. [PDF]

open access: yesJ Cardiovasc Med (Hagerstown)
AIMS: Presence of family cases and multiple recurrences of pericarditis suggest the existence of a possible genetic background in at least 10% of cases.
Imazio M   +8 more
europepmc   +2 more sources

Colchicine in Treatment of Intractable Postpericardiotomy Syndrome in an Elderly Patient

open access: yesInternational Journal of Gerontology, 2011
Postpericardiotomy syndrome is a specific type of acute pericarditis because of a delayed pericardial and/or pleural reaction after thoracic surgery. Relapse after aspirin, nonsteroidal anti-inflammatory drug, and/or steroid treatment or intractable to ...
Lin-Shong Li, Chun-Fu Chen, Der-Yan Tai
doaj   +1 more source

Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis [PDF]

open access: yes, 2022
Interleukin 1 (IL-1) has been indicated as a mediator of recurrent pericarditis. Rilonacept, a soluble IL-1 receptor chimeric fusion protein neutralizing interleukin 1 alpha (IL-1α) and interleukin 1 beta (IL-1β), has demonstrated promising results in a ...
Amen, Shwan   +12 more
core   +5 more sources

Acute and recurrent pericarditis [PDF]

open access: yesVnitřní lékařství, 2019
Pericardial diseases have been until recently relatively neglected entity; however, there has been a markedly increased interest in these disorders in the last decade due to new diagnostic as well as therapeutic options. Various clinical manifestations of pericardial diseases may be generally grouped into pericardial syndromes including pericarditis ...
openaire   +2 more sources

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review

open access: yesCardiology Research and Practice, 2016
Recurrent pericarditis is a complication of acute pericarditis in 20–30% of the patients and is usually idiopathic in nature. The underlying pathogenesis of this condition remains unclear, although immune-mediated mechanisms seem likely.
Shankar Baskar   +2 more
doaj   +1 more source

A risk score for pericarditis recurrence

open access: yesEuropean Journal of Clinical Investigation, 2021
AbstractBackgroundCurrently, we remain uncertain about which patients are at increased risk for recurrent pericarditis. We developed a risk score for pericarditis recurrence in patients with acute pericarditis.Materials and methodsWe prospectively recruited 262 patients with a first episode of acute pericarditis.
Emilia Lazarou   +10 more
openaire   +4 more sources

Recurrent pericarditis: an update on diagnosis and management

open access: yes, 2021
Recurrent pericarditis is a true challenge for clinicians, especially when the patient becomes unresponsive or not tolerant to conventional treatments.
Brucato, Antonio   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy